Amicus Therapeutics
FOLD
FOLD
205 hedge funds and large institutions have $3.41B invested in Amicus Therapeutics in 2019 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 77 increasing their positions, 54 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
37% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 27
5% more funds holding
Funds holding: 195 → 205 (+10)
10.26% less ownership
Funds ownership: 122.29% → 112.02% (-10%)
Holders
205
Holding in Top 10
10
Calls
$26.9M
Puts
$8.15M
Top Buyers
| 1 | +$154M | |
| 2 | +$75.7M | |
| 3 | +$36M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$28.6M |
| 5 |
Millennium Management
New York
|
+$27.3M |
Top Sellers
| 1 | -$37.6M | |
| 2 | -$36.4M | |
| 3 | -$22.3M | |
| 4 |
Morgan Stanley
New York
|
-$19.2M |
| 5 |
Jennison Associates
New York
|
-$16.3M |